Roflumilast

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 31722-623
  • Package NDC 31722-623-30
  • Package NDC 31722-623-32
  • Package NDC 31722-623-90
  • Application number ANDA208213
  • SPL ID fa61de4b-e3e1-e16c-e053-6394a90a6118
  • SPL set ID f25a0230-3cf6-4366-bebe-0ea5ff8de5ab
  • UNII 0P6C6ZOP5U
  • RxCUI 1091839
  • RxCUI 2001319

What the source publishes

Labeler
Camber Pharmaceuticals, Inc.
Active ingredients
Roflumilast
Form
TABLET
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:31722-623_fa61de4b-e3e1-e16c-e053-6394a90a6118
{
  "name": "Roflumilast",
  "splId": "fa61de4b-e3e1-e16c-e053-6394a90a6118",
  "labels": [
    {
      "setId": "f25a0230-3cf6-4366-bebe-0ea5ff8de5ab",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f25a0230-3cf6-4366-bebe-0ea5ff8de5ab",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f25a0230-3cf6-4366-bebe-0ea5ff8de5ab"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Camber Pharmaceuticals, Inc.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "30 TABLET in 1 BOTTLE (31722-623-30)",
      "package_ndc": "31722-623-30",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20221015"
    },
    {
      "sample": false,
      "description": "100 BLISTER PACK in 1 CARTON (31722-623-32)  / 10 TABLET in 1 BLISTER PACK (31722-623-31)",
      "package_ndc": "31722-623-32",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20221015"
    },
    {
      "sample": false,
      "description": "90 TABLET in 1 BOTTLE (31722-623-90)",
      "package_ndc": "31722-623-90",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20221015"
    }
  ],
  "productId": "31722-623_fa61de4b-e3e1-e16c-e053-6394a90a6118",
  "useDomain": "unknown",
  "dosageForm": "TABLET",
  "productNdc": "31722-623",
  "deaSchedule": null,
  "genericName": "Roflumilast",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "ROFLUMILAST",
      "strength": "500 ug/1"
    }
  ],
  "applicationNumber": "ANDA208213",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20221015",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000182961",
      "N0000182960"
    ],
    "upc": [
      "0331722623902",
      "0331722623308"
    ],
    "unii": [
      "0P6C6ZOP5U"
    ],
    "rxcui": [
      "1091839",
      "2001319"
    ],
    "spl_set_id": [
      "f25a0230-3cf6-4366-bebe-0ea5ff8de5ab"
    ],
    "pharm_class_epc": [
      "Phosphodiesterase 4 Inhibitor [EPC]"
    ],
    "pharm_class_moa": [
      "Phosphodiesterase 4 Inhibitors [MoA]"
    ],
    "manufacturer_name": [
      "Camber Pharmaceuticals, Inc."
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:31722-623_fa61de4b-e3e1-e16c-e053-6394a90a6118"